Fast Market Research

New Market Report: Global Macular Edema Market 2014-2018

Fast Market Research recommends "Global Macular Edema Market 2014-2018 " from TechNavio, now available


Boston, MA -- (SBWIRE) -- 07/24/2014 -- Macular edema results from fluid accumulation in the macular region of the retina. Macular edema arises from various etiologies such as diabetes, AMD, and RVO. Macular edema disrupts the central vision due to swelling of the macula. Currently, the treatment plan involves the use of surgical and laser therapies as well as drugs such as anti-VEGF therapies and NSAIDs. Surgery and laser therapy are intended to prevent further damage to vision. However, anti-VEGF therapies have been reported to improve the vision loss associated with macular edema.

TechNavio's analysts forecast the Global Macular Edema market will grow at a CAGR of 9.1 percent over the period 2014-2018.

View Full Report Details and Table of Contents

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Macular Edema market for the period 2013-2018. To calculate the market size, the report considers revenue generated through the sales of various drugs administered to treat macular edema associated with distinct etiologies.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Macular Edema market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the Global Macular Edema Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Macular Edema market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas

Key Vendors

- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.

Other Prominent Vendors

- Alcon Inc.
- Alimera Sciences Inc.
- Allergan Inc.
- Ampio Pharmaceuticals Inc.
- iCo Therapeutics Inc.
- Pfizer Inc.
- Santen Pharmaceutical Co. Ltd.

Key Market Driver

- Increase in Patient Population
- For a full, detailed list, view our report.

Key Market Challenge

- Increasing Use of Off-label Drugs
- For a full, detailed list, view our report.

Key Market Trend

- Increasing Recommendations by NICE
- For a full, detailed list, view our report.

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Alimera Sciences Inc., Allergan Inc., Ampio Pharmaceuticals Inc., iCo Therapeutics Inc.,Pfizer Inc., Santen Pharmaceutical Co. Ltd.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Diabetic Macular Edema - Pipeline Review, H1 2014
- Diabetic Macular Edema - Pipeline Review, H1 2013
- Macular Edema - Pipeline Review, H2 2013
- Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014
- Pulmonary Edema Global Clinical Trials Review, H2, 2013
- Macular Degeneration Therapeutics Market in Asia-Pacific to 2019 - Existing Angiogenics Retain Dominance Though High Unmet Need Remains
- Age Related Macular Degeneration - Pipeline Review, H1 2014
- Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014
- Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2014
- Global Age-Related Macular Degeneration (AMD) Market 2014-2018